Week In Review: Biopharma Deals Slow During Chinese New Year Week

Amid a slow week, Shanghai's HanBio Therapeutics raised $40 million in a Series A financing to advance its innovative biologic products. HanBio is an early R&D company that was incubated by Sunshine Guojian Pharma.